Home

Current Issue

Archives

Guidelines sfor Authors

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

E-mail Alert Service

Contact Info

Editorials

Endogenous Retroviruses in Pathogenesis of Autoimmunity

A. Perl .........461

Primary Angiitis of the CNS: The Penumbra of Vasculitis

L. Calabrese .........465

Should the Initial Drug Used to Treat OA Pain Be a Nonsteroidal Antiinflammatory Drug?

K.D. Brandt, J.D. Bradley .........467

Articles

Hypothesis Rheumatoid Arthritis and Hepatitis B Virus: Evaluating the Pathogenic Link

A. Csepregi, E. Nenesánszky, B. Rojkovich, G. Poór .........474

Identification of a6b1 Integrin Positive Cells in Synovial Lining Layer as Type B Synoviocytes
 
L. Pirilä, H. Aho, A. Roivainen, Y.T. Konttinen, L.J. Pelliniemi, J. Heino .........478

Correlations Between MMP-9 and Adenosine Deaminase Isozymes in SF from Patients with RA
 
S. Iwaki-Egawa, Y. Watanabe, H. Matsuno .........485

Serum Levels of IL-6 and Stress Related Substances Indicate Mental Stress Condition in Patients with RA
 
D. Hirano, M. Nagashima, R. Ogawa, S. Yoshino .........490

Enhanced in Vitro Induced Production of IL-10 by PBMC in RA Is Associated with Clinical Response to MTX Treatment
 
M. Seitz, M. Zwicker, B. Wider .........496

MTX Stimulates Lung Fibroblasts and Epithelial Cells to Release Eosinophil Chemotactic Activity
 
E. Sato, S.L. Camhi, S. Koyama, R.A. Robbins .........502

Relationship Between Parity and Clinical and Biological Features in Patients with SSc
 
D. Launay, M. Hebbar, P-Y. Hatron, et al .........509

Persistent Increase in Plasma Thrombomodulin in Patients with a History of Lupus Nephritis: Endothelial Cell Activation Markers
 
R. Frijns, R. Fijnheer, A. Schiel, R. Donders, J. Sixma, R. Derksen .........514

Isotypes of Anti-ß₂-Glycoprotein I Antibodies: Association with Thrombosis in Patients with SLE
 
S-S. Lee, M-L. Cho, Y-S. Joo, et al .........520

The Relationship Between Health Related Quality of Life and Disease Activity and Damage in SLE
 
C. Wang, N.E. Mayo, P.R. Fortin .........525

Quantitative Analyses of mRNA of Human Endogenous Retrovirus in Patients with SLE
 
H. Ogasawara, T. Naito, H. Kaneko, et al .........533

SLE in the Arctic Region of Norway
 
H.C. Nossent .........539

Whole Body and Regional BMD in AS
 
F.P. Dos Santos, A. Constantin, M. Laroche, et al .........547

Familial Aggregation of Ankylosing Spondylitis in Southern China
 
Y. Liu, J. Li, B. Chen, H. Helenius, K. Granfors .........550

SpA in Japan: Nationwide Questionnaire Survey Performed by The Japan Ankylosing Spondylitis Society
 
S. Hukuda, M. Minami, T. Saito, et al .........554

Primary AS: Patterns of Disease in a Brazilian Population of 147 Patients
 
P.D. Sampaio-Barros, M.B. Bertolo, M.H. Stangler Kraemer, J.F. Marques Neto, A.M. Samara .........560

Prevention of Corticosteroid Induced Osteoporosis in Inpatients Recently Discharged from a Tertiary Teaching Hospital
 
M.D. Smith, S.P. Cheah, K. Taylor, M.J. Ahern .........566

Gender Differences in the Relationships of Serum Uric Acid with Fasting Serum Insulin and Plasma Glucose in Patients without Diabetes
 
P. Chou, K-C. Lin, H-Y. Lin, S-T. Tsai .........571

Treatment of Chronic Gout. Can We Determine When Urate Stores Are Depleted Enough to Prevent Attacks of Gout?
 
J. Li-Yu, G. Clayburne, M. Sieck, et al .........577

Abnormal Sympathovagal Balance in Men with FM
 
H. Cohen, L. Neumann, A. Alhosshle, M. Kotler, M. Abu-Shakra, D. Buskila .........581

FM and Chronic Widespread Pain in Patients with IBD: A Cross Sectional Population Survey
 
Ø. Palm, B. Moum, J. Jahnsen, J.T. Gran .........590

Antibodies Against Serotonin Have No Diagnostic Relevance in Patients with FM
 
E. Werle, H.P. Fischer, A. Müller, W. Fiehn, W. Eich .........595

Comparison of Viral Antibodies in 2 Groups of Patients with FM
 
I. Hechmann Wittrup, B. Jensen, H. Bliddal, B. Danneskiold-Samsøe, A. Wiik .........601

Pediatric Rheumatology

Risk Factors for Development of Lower Limb Pain in Adolescents
 
I. Shrier, D. Ehrmann-Feldman, M. Rossignol, L. Abenhaim .........604

Lipodystrophy in Patients with JDM — Evaluation of Clinical and Metabolic Abnormalities
 
C. Huemer, H. Kitson, P.N. Malleson, et al .........610

Case Report: Primary Angiitis of the CNS in Children: 5 Cases
 
K.T. Gallagher, B. Shaham, A. Reiff, et al .........616

Case Reports

Cricoarytenoid Arthritis with RA and SLE
 
Y. Nanke, S. Kotake, K. Yonemoto, M. Hara, M. Hasegawa, N. Kamatani .........624

Lumbar Pannus Presenting as Cauda Equina Syndrome in a Patient with Longstanding RA
 
K.P. White, M. Harth .........627

Localized Neurological Necrotizing Vasculitides. Three Cases with Isolated Mononeuritis Multiplex
 
S. Abgrall, L. Mouthon, P. Cohen, et al .........631

Images in Rheumatology

Relapsing Polychondritis and Erythema Elevatum Diutinum: an Unusual Association Refractory to Dapsone

J. Delgado, J. Gomez-Cerezo, F.J. Barbado, J.J. Vazquez, M. Sigüenza, J-L. Dupond .........634

Workshop Report

Ninth International Conference on Behçet's Disease, Seoul, Korea, May 27-29, 2000

M. Schirmer, K.T. Calamia, H. Direskeneli .........636

OMERACT 5

International Consensus Conference on Outcome Measures in Rheumatology, Toulouse, France, May 4-8, 2000

Introduction: Economics Working Group Report

S.E. Gabriel .........640

Issues of Consensus and Debate for Economic Evaluation in Rheumatology
 
D. Coyle, V. Welch, B. Shea, S. Gabriel, M. Drummond, P. Tugwell .........642

Rating of Arthritis Health States by Patients, Physicians, and the General Public. Implications for Cost-Utility Analyses
 
M.E. Suarez-Almazor, B. Conner-Spady .........648

Development of a Matrix of Cost Domains in Economic Evaluation of RA
 
S. Merkesdal, J. Ruof, J.L. Huelsemann, et al .........657

Cost Assessment Instruments in Rheumatology: Evaluation of Applied Instrument Characteristics
 
J. Ruof, S. Merkesdal, J.L. Huelsemann, et al .........662

OMERACT: Economic Evaluations and Health Policy
 
B. Ruff .........666

OMERACT 5 Economics Working Group: Summary, Recommendations, and Research Agenda

S. Gabriel, M. Drummond, D. Coyle, et al .........670

Correspondence

Fibromyalgia and the Law
T.J. Romano .........674

Letter
R. Ferrari, A. Russell .........675

Reply
A. Mailis, A. Taylor .........675

Letter
M.J. Pellegrino .........676

Reply
F. Wolfe .........677

The Epidemiology of PsA
S.E. Gabriel .........678

Reply
D. Veale .........678

Letters 

Extensive Pigmentation Secondary to Minocycline Treatment of RA
S.A. Assad, E.F. Bernstein, B. Brod, W.D. James .........679

Termination of DMARD in PsA
I. Ujfalussy, É. Koó .........682

Beaver Fever — A Rare Cause of ReA
P. Borman, Ü. Seçkin, K. Özoran .........683

Book Reviews

Diseases of Skeletal Muscle .........683

Pediatric Rheumatic Diseases .........684

Correction

Polymorphisms of the Interleukin 10 Gene Promoter Are Not Associated with Anti-Ro Autoantibodies in Primary Sjögren's Syndrome [letter]
M. Rischmueller, V. Limaye, S. Lester, et al .........684

Notices